Caldwell Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80
Closed -$7.88K 792
2025
Q3
$7.88K Hold
80
﹤0.01% 658
2025
Q2
$7.3K Sell
80
-6
-7% -$580 ﹤0.01% 660
2025
Q1
$9.73K Buy
86
+83
+2,767% +$8.88K ﹤0.01% 638
2024
Q4
$317 Hold
3
﹤0.01% 709
2024
Q3
$324 Buy
+3
New +$327 ﹤0.01% 700
2022
Q4
Sell
-40
Closed -$4.18K 748
2022
Q3
$4.18K Hold
40
﹤0.01% 666
2022
Q2
$4.2K Hold
40
﹤0.01% 691
2022
Q1
$5.12K Sell
40
-1
-2% -$121 ﹤0.01% 686
2021
Q4
$5.08K Hold
41
﹤0.01% 680
2021
Q3
$5.85K Hold
41
﹤0.01% 664
2021
Q2
$6.43K Sell
41
-24
-37% -$3.89K ﹤0.01% 667
2021
Q1
$10.1K Sell
65
-824
-93% -$128K ﹤0.01% 630
2020
Q4
$133K Sell
889
-2,832
-76% -$400K 0.02% 303
2020
Q3
$492K Sell
3,721
-732
-16% -$95.6K 0.08% 170
2020
Q2
$516K Sell
4,453
-643
-13% -$74.1K 0.09% 170
2020
Q1
$500K Sell
5,096
-309
-6% -$40.5K 0.09% 157
2019
Q4
$786K Buy
+5,405
New +$746K 0.12% 138

Other funds holding ZBH

Caldwell Trust's ZBH Position: Q4 2025 in Review

Caldwell Trust sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 80 shares — an estimated $7.88K sold.

Caldwell Trust first reported a position in ZBH in Q4 2019 and held it in 17 quarters. The position peaked at $786K in Q4 2019. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Caldwell Trust reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Caldwell Trust sold 80 Zimmer Biomet shares in Q4 2025, an estimated $7.88K.
  • Caldwell Trust first reported a position in Zimmer Biomet in Q4 2019 and held it in 17 quarters.
  • Caldwell Trust's Zimmer Biomet position peaked at $786K in Q4 2019.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Caldwell Trust's 13F filing for Q4 2025, filed 30 Jan 2026.